MarketCatalyst
← Back to Resources
Earnings

Tyson Foods Beats Fiscal Q4 2026 Estimates as Revenue Rises 5.2% to $14.59B

Revenue of $14.59B vs. $14.04B expected and adjusted EPS of $0.61 vs. $0.53; revenue up 5.2% from a year earlier.

Published Nov 16, 2026 · 7:33 AM ET · 2 min read

Tyson Foods (TSN) beat estimates for the fiscal fourth quarter of 2026 on both revenue and adjusted EPS. Revenue was $14.59 billion, up 5.2% from a year earlier, above the $14.04 billion estimate, and adjusted EPS was $0.61, down 47% from a year earlier, above the $0.53 estimate.

Shares rose 0.3% in premarket trading as of 7:29 a.m. ET, to $58.98 from a $58.82 close.

$0.61
Adjusted EPS, down 47% YoY vs. $0.53 estimate
$14.59B
Revenue, up 5.2% YoY vs. $14.04B estimate
+0.3%
Shares premarket as of 7:29 a.m. ET

Fiscal Q4 2026 scorecard

ParametersExpectedActualBeat/Miss
Adjusted EPS$0.53$0.61Beat by 15%
Revenue$14.04B$14.59BBeat by 3.9%
ChangeYoYQoQ
Adjusted EPS▼ 47%▼ 38%
Revenue▲ 5.2%▲ 5.2%

By our calculation, revenue was $548.0 million above the estimate and adjusted EPS was $0.08 above it. The QoQ column compares with the previous quarter's revenue of $13.87 billion and adjusted EPS of $0.99. The YoY column compares with $13.86 billion and $1.15 in the same quarter a year earlier.

Track record

  • EPS record. Adjusted EPS beat the estimate in 6 of the last 8 reports, including this one.
  • Revenue record. Revenue beat the estimate in 4 of the last 8 reports.
  • Revenue trend. Revenue over the last 5 reports, oldest first: $13.86 billion, $14.31 billion, $13.65 billion, $13.87 billion and $14.59 billion.

What to watch

  • Next-quarter estimates. Consensus calls for EPS of $0.95 and revenue of $14.27 billion next quarter, based on 4 analysts.
  • Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 5.2% increase to $14.59 billion.
  • Estimate record. Whether Tyson Foods extends a record of beating EPS estimates in 6 of its last 8 reports.
  • Related coverage. See our reports on Aramark, Inhibrx Biosciences, HawkEye 360 and Almonty Industries.

Sources: Results are from Tyson Foods's Nov. 16, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Tyson Foods's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.

Readers also read

MarketCatalyst is not a registered investment advisor and does not manage client assets. Content on this platform is provided for informational and educational purposes only. It is not investment advice, and MarketCatalyst is not a stock-picking or trade-alert service. Trading stocks and options involves risk, including the possible loss of principal. Consider your own goals, time horizon, and risk tolerance, and consult a qualified financial advisor before making any investment decision.